A biopharmaceutical company that develops proprietary vaccines for emerging diseases has signed a lease to double its headquarters footprint at the Riverside Technology Park in Frederick, Maryland.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- Contacts
- Danny Foit
Leasing Representative, St. John Properties